Advanced targeted, cell and gene therapy approaches for pediatric hematological malignancies: results and future perspectives
Despite the survival of pediatric patients affected by hematological malignancies being improved in the last 20 years by chemotherapy and hematopoietic stem cell transplantation (HSCT), a significant amount of patients still relapses. Treatment intensification is limited by toxic side effects and is...
| Autors principals: | , , , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Frontiers Media S.A.
2013-04-01
|
| Col·lecció: | Frontiers in Oncology |
| Matèries: | |
| Accés en línia: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00106/full |